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Al~traet 
Reduced pyridine nucleotide has been reported to enhance cell-free transfer of membrane material from a radiolabeled Golgi apparatus donor 
fraction from rat liver to an acceptor f action consisting of inside-out plasma vesicles immobilized on nitrocellulose [(1992) Bioehim. Biophys. Acta 
1107, 131]. As part of a continuing effort to identify NADH-requiring enzymes in the Goigi apparatus which may be important to membrane 
trafficking, highly purified fractions of Golgi apparatus from rat liver were tested for their ability to oxidize NADH and the inhibition of the oxidation 
of NADH by brefeldin A. The isolated Golgi apparatus fractions were found to oxidize NADH with a specific activity comparable to that of the 
plasma membrane of rat liver. The activity was inhibited by brefeldin A and this inhibition was augmented by GDP. At near optimal concentrations 
of 7/tM brefeldin A and 1/aM GDP, the activity was > 90% inhibited. Brefeldin A inhibition of NADH oxidation by the Golgi apparatus was 
time-dependent and GDP appeared to accelerate the inhibition by brefeidin A. 
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1. Introduction 
Brefeldin A (BFA) is a heterocyclic lactone (macrolide 
antibiotic) with potent inhibitory effects on trafficking to 
and through the Golgi apparatus [1]. Transport of G 
protein is inhibited in vesicular stomatitis virus-infected 
baby hamster kidney cells [2], and secretion of plasma 
proteins, such as albumin and al-protease inhibitor, are 
blocked in rat hepatocytes [3,4]. Despite earlier indica- 
tions that brefeldin A resulted in more or less complete 
disassembly of the Golgi apparatus and its relocation to 
the endoplasmic reticulum [1-7], it now appears that, in 
most instances, a modified Golgi apparatus remains 
[8,9]. 
Brefeldin causes rapid dissociation of a 110 kDa pro- 
tein from Golgi apparatus membranes [10]. This protein, 
fl-COP, is a component of the non-clathrin-coated vesi- 
cles that accumulate as the Golgi apparatus-associated 
buds when intercisternal transport is blocked by GTP-~,- 
S [11,12]. Most recently, secretion of [3sS]SO4-1abeled 
secretogranin II from PC 12 cells, a marker of secretory 
granule budding from the trans-Golgi network (TGN), 
was found to be blocked by brefeldin A [13]. These find- 
ings suggest that brefeldin A may exert similar effects on 
both pre- and post-Golgi apparatus compartments, 
blocking forward transport but not the return pathway 
[13]. This inhibition of transport by brefeldin A may be 
through interactions with low molecular weight GTP- 
binding proteins [14--16] that influence coatomer bind- 
ing. An exchange enzyme that catalyzes guanine nucleo- 
tide exchange and promotes binding of ADP-ribosyla- 
tion factor (ARF) and other accessory proteins by the 
Golgi apparatus, for example, has been described as the 
potential primary target for brefeldin A [17,18]. 
In our studies, we have reconstituted vesicular mem- 
brane trafficking between the transitional endoplasmic 
reticulum and the Golgi apparatus of rat liver (e.g. [19]). 
Progress has also been made in reconstituting vesicular 
membrane traffic between the Golgi apparatus and the 
plasma membrane [16]. Here a transient transfer of radi- 
olabeled membrane constituents between isolated trans- 
Golgi apparatus elements and inside-out vesicles of the 
plasma membrane was found to be temperature-depend- 
ent but independent of ATP either in the presence or 
absence of cytosol. Instead of ATP, the transfer was 
stimulated by reduced pyridine dinucleotide (NADH) 
[201. 
Consequently, NADH-requiring reactions potentially 
involved in membrane trafficking were sought. An 
NADH-ferricyanide oxidoreductase was localized previ- 
ously to the Golgi apparatus of rat liver [21,22]. How- 
ever, the natural endogenous acceptor of this activity 
was not determined. In this report we describe a Golgi 
apparatus NADH oxidase activity that is inhibited by 
brefeldin A. This inhibition appears to be accelerated by 
GDP. 
* Corresponding author. Address: Department of Medicinal 
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University, West Lafayette, IN 47907, USA. Fax: (1) (317) 494-4007. 
Abbreviations." BFA, brefeldin A; fl-COP, fl coatomer protein; GTP-y- 
S, guanosine 5"-O-(3-thiophosphate). 
2. Materials and methods 
Golgi apparatus were purified from livers of male Holtzman rats as 
described [23]. The fractions were verified by electron microscopy and 
analysis of marker enzymes to be at least 90% Golgi apparatus-derived 
material. 
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NADH oxidase was determined as the disappearance of NADH 
measured at340 nm in a reaction mixture containing 25 mM Tris-MES 
buffer (pH 7.0), 1 mM KCN to inhibit any contaminating mitochon- 
drial NADH oxidase activity, and 150 gM NADH at 37°C with con- 
stant stirring. Activity was measured with a Hitachi U3210 spectro- 
photometer with continuous recording over 5 min intervals. A millimo- 
lar extinction coefficient of 6.22 was used to determine the specific 
activity of the NADH oxidase. 
Brefeldin A was added as an ethanol solution: an equivalent amount 
of ethanol was added to controls. Experiments were repeated in tripli- 
cate and averaged. Standard eviations were calculated from the means 
of the three experiments. 
3. Results 
Isolated rat liver Golgi apparatus exhibited steady- 
state NADH oxidase activities of 1.0 + 0.2 nmol NADH 
oxidized/min/mg protein. Activity was proportional to 
protein concentration a d exhibited linearity for 60 rain 
or longer. Assays were at non-rate-limiting NADH con- 
centrations and pH. 
Increasing concentrations of brefeldin A within the 
normal 10 min NADH oxidase activity exhibited amax- 
imum inhibition of about 30% at 7 ltM BFA (Fig. 1). 
However, if 1 gM GDP was added to the assay mixture 
the inhibition was nearly doubled over a subsequent 5 
min assay. An amount of ethanol equivalent to that 
added with the brefeldin A was without effect, and 1 gM 
GDP stimulated NADH oxidase activity slightly, either 
alone or added to the ethanol (Fig. 1). 
The response of the NADH oxidase activity of rat liver 
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Fig. 1. Inhibition of the NADH oxidase activity of rat liver Golgi 
apparatus as a function of the concentration of brefeldin A and aug- 
mentation of the inhibition by 1 gM GDP. Ethanol alone (A) and 
ethanol + I gM GDP (A) were largely without effect on the activity. 
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Fig. 2. Response of the NADH oxidase activity of rat liver Golgi 
apparatus to increasing concentrations of GDP. In the absence of 
brefeldin A, GDP was either inhibitory or without effect. 
Golgi apparatus to GDP is illustrated further in Fig. 2. 
In the absence of brefeldin A, GDP at all concentrations 
tested was either without effect or slightly stimulatory. 
Not only was there no dose-dependent i hibition of 
NADH oxidase activity over a 5-10 min assay period by 
GTP at any concentration tested, but GDP was not in- 
hibitory even with prolonged periods of incubation of up 
to 30 min. 
At a near optimum concentration f 7 gM brefeldin 
A and varying concentrations of GDP, subsequent inhi- 
bition of the two substances added together was near 
maximal at about 1 pM GDP (Fig. 3). The combination 
of brefeldin A plus GDP was very effective in inhibiting 
NADH oxidase activity. Inhibitions of 90% or greater 
were routinely achieved. 
Brefeldin A alone also exhibited substantial inhibition 
of NADH oxidase in a time-dependent manner (Fig. 4). 
Times of incubation of 40 min or longer were required 
in the absence of GDP before substantial inhibitions 
were observed. No loss of enzymatic activity was ob- 
served over the same period of time in the presence of 
equivalent amounts of ethanol alone. 
4. Discussion 
An established characteristic of the action of brefeldin 
A on cells is that he compound prevents the exit of newly 
synthesized proteins from the endoplasmic reticulum 
D.J. Morr6 et al. IFEBS Letters 346 (1994) 199-202 201 
Z 
[ ]  
I-- 
0 
Iz: 
13. 
' 5  
z 
0.9 
0.8 
0.7 
7 pM BFA 
._,'"on 0.6 i 
o 0.5 
Z 
>" 0.4 I.-- 
I,-- 
o 0.3 
iii 
o~ 
< 0.2 
X 
0 
-,. 0.1 
z 0 ~ 
0 BFA -10 -9 -8 -7 -6 -5 -4 
LOG [GDP], M 
Fig. 3. Inhibition of the NADH oxidase of rat liver Golgi apparatus by
7 uM brefeldin A (BFA), and augmentation of the inhibition by increas- 
ing GDP concentrations. Activity was ca. 90% inhibited following the 
addition of 1 pM GDR 
(ER) [3,4]. The Golgi apparatus structure is rapidly dis- 
rupted and what has been interpreted as microtubule- 
dependent retrograde transport of Golgi apparatus en- 
zymes back to the ER is induced [6,7,24,25]. Thus, bre- 
feldin A blocks forward transport while retrograde 
transport appears to continue. 
The basis for the block in forward transport has been 
attributed, at least in part, to an interruption ofcoatomer 
attachment to Golgi apparatus-associated v sicles [26]. 
Donaldson et al. [10] showed that brefeldin A caused the 
dissociation of a 110 kDa protein, fl-COP, from Golgi 
apparatus membranes in less than 15 s. fl-COP has been 
demonstrated to be present on non-clathrin-coated buds 
that accumulate when intercisternal Golgi apparatus 
transport is blocked by GTP-F-S [11,12]. Formation of 
these buds is prevented in vitro by brefeldin A [27]. 
It is possible that fl-COP and the coatomer complex 
also function in more distal parts of the Golgi complex. 
For example, Miller et al. [13] showed that secretion of 
[35S]SO4-1abeled secretogranin II from PC12 cells was 
blocked by brefeldin A whereas endocytic traffic was 
not. The sulfated secretogranins have been widely em- 
ployed to study secretory granule budding from the 
trans-Golgi apparatus network [28]. 
One explanation for how brefeldin A might prevent 
the assembly of coatomer onto the membrane has come 
from studies that demonstrate inhibition of the GTP- 
dependent interaction of ADP-ribosylation factor (ARF) 
with the Golgi apparatus membranes [17,18,29,30]. Ad- 
ditionally, recruitment of the Golgi-specific AP-1 adap- 
tor complex onto Golgi membrane involved in clathrin 
coat assembly required ARF [31], and this recruitment 
was also sensitive to brefeldin A. ARF binding to iso- 
lated Golgi apparatus was hormone receptor- and pro- 
tein kinase C-mediated [32], and inactive analogs of bre- 
feldin A did not inhibit nucleotide xchange and accessor 
protein binding by the Golgi apparatus [18,33]. The tar- 
get for brefeldin A would then be the exchange nzyme 
that catalyzed guanine nucleotide xchange on the ARF- 
1 protein [17,18]. ARF-I(T31N) mutant protein, a pro- 
tein with a putative preferential affinity for GDP com- 
pared to the wild-type protein, was shown to inhibit 
export from the ER and trigger a brefeldin A-like pheno- 
type in HeLa cells [35]. 
Interaction with an exchange nzyme that catalyzes 
guanine nucleotide xchange may be important as well 
as help explain our findings concerning the brefeldin A 
plus GDP inhibition of the NADH oxidase activity. The 
NADH oxidase of rat liver plasma membranes does re- 
spond to guanine nucleotides, GTP-7-S, mastoparan and 
aluminum fluoride [36]. The activity is growth factor- 
and hormone-responsive with plasma membranes of rat 
liver [37], but is constitutively activated and no longer 
growth factor- and hormone-responsive in plasma mem- 
branes from rat hepatomas [38]. Alteration of a guanine 
nucleotide xchange activity similar to that involved with 
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Fig. 4. Time-dependent i hibition of the NADH oxidase of rat liver 
Golgi apparatus by 7 pM brefeldin A (BFA): GDP may only serve to 
accelerate he rate of BFA inhibition of the oxidase. Even in the absence 
of added GDP, BFA inhibited the NADH oxidase in a time-dependent 
manner to a maximum at about 45 min. In the absence of BFA (equiv- 
alent amount of ethanol alone), the activity was not inhibited. 
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ARF and accessory protein binding to Golgi apparatus 
membranes [17,18] could help to explain how GDP and 
brefeldin A interact o inhibit Golgi apparatus NADH 
oxidase activity. 
Added interest in the inhibition of the NADH oxidase 
activity by brefeldin A is provided by the previously 
reported enhancement of cell-free transfer from Golgi 
apparatus to plasma membrane augmented by NADH 
[20]. As such, the activity may provide a convenient tool 
for the future elucidation of both the action of brefeldin 
A in blocking Golgi apparatus membrane traffic, and for 
the possible resolution of the role of reduced pyridine 
nucleotide in Golgi apparatus to plasma membrane ves- 
icle transfer. 
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